Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.23.3
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Revenue:    
Total revenues $ 0 $ 0
Operating expenses    
Royalties and license fees (106) 0
Research and development 4,429 2,660
General and administrative 1,551 1,920
Total operating expenses 5,874 4,580
Loss from operations (5,874) (4,580)
Other income (loss):    
Foreign currency transaction loss (56) (507)
Interest expense, net (6) (9)
Other expense, net (18) 0
Unrealized gain on investment 0 3
Total other loss, net (80) (513)
Net loss (5,954) (5,093)
Other comprehensive income:    
Unrealized foreign currency translation gain 50 507
Total other comprehensive income 50 507
Total comprehensive loss $ (5,904) $ (4,586)
Net loss per share: basic $ (2.76) $ (7.98)
Net loss per share: diluted $ (2.76) $ (7.98)
Weighted average number of shares outstanding: basic 2,157,065 638,572
Weighted average number of shares outstanding: diluted 2,157,065 638,572